Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Tumor-treating fields induce autophagy by blocking the Akt2/miR29b axis in glioblastoma cells.

Kim EH, Jo Y, Sai S, Park MJ, Kim JY, Kim JS, Lee YJ, Cho JM, Kwak SY, Baek JH, Jeong YK, Song JY, Yoon M, Hwang SG.

Oncogene. 2019 Sep;38(39):6630-6646. doi: 10.1038/s41388-019-0882-7. Epub 2019 Aug 2.

PMID:
31375748
2.

MicroRNA-652 suppresses malignant phenotypes in glioblastoma multiforme via FOXK1-mediated AKT/mTOR signaling pathway.

Yang H, Song Z, Wu X, Wu Y, Liu C.

Onco Targets Ther. 2019 Jul 10;12:5563-5575. doi: 10.2147/OTT.S204715. eCollection 2019.

3.

The role of AKT isoforms in glioblastoma: AKT3 delays tumor progression.

Joy A, Kapoor M, Georges J, Butler L, Chang Y, Li C, Crouch A, Smirnov I, Nakada M, Hepler J, Marty M, Feuerstein BG.

J Neurooncol. 2016 Oct;130(1):43-52. Epub 2016 Jul 15.

4.

MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3.

Teng Y, Zhang Y, Qu K, Yang X, Fu J, Chen W, Li X.

Oncotarget. 2015 Dec 1;6(38):40799-814. doi: 10.18632/oncotarget.5695.

5.

Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies.

Mittal S, Klinger NV, Michelhaugh SK, Barger GR, Pannullo SC, Juhász C.

J Neurosurg. 2018 Feb;128(2):414-421. doi: 10.3171/2016.9.JNS16452. Epub 2017 Feb 24.

PMID:
28298023
6.

Tumor Treating Fields Utilization in a Glioblastoma Patient with a Preexisting Cardiac Pacemaker: The First Reported Case.

McClelland S 3rd, Henrikson CA, Ciporen JN, Jaboin JJ, Mitin T.

World Neurosurg. 2018 Nov;119:58-60. doi: 10.1016/j.wneu.2018.07.162. Epub 2018 Jul 29.

PMID:
30064027
7.

Tumor treating fields: a novel and effective therapy for glioblastoma: mechanism, efficacy, safety and future perspectives.

Zhu P, Zhu JJ.

Chin Clin Oncol. 2017 Aug;6(4):41. doi: 10.21037/cco.2017.06.29. Review.

8.
9.

miR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2.

Chung HJ, Choi YE, Kim ES, Han YH, Park MJ, Bae IH.

Oncotarget. 2015 Jul 30;6(21):18429-44.

10.

Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis.

Kim EH, Song HS, Yoo SH, Yoon M.

Oncotarget. 2016 Oct 4;7(40):65125-65136. doi: 10.18632/oncotarget.11372.

11.

Tumour Treating Fields (TTFs) for recurrent and newly diagnosed glioblastoma multiforme.

Mirza FA, Shamim MS.

J Pak Med Assoc. 2018 Oct;68(10):1543-1545. Review.

12.

Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking.

Zhao B, Shen C, Zheng Z, Wang X, Zhao W, Chen X, Peng F, Xue L, Shu M, Hou X, Wang K, Zhong C, Sun J, Wan J, Zhao S.

Cell Physiol Biochem. 2018;51(4):1566-1583. doi: 10.1159/000495646. Epub 2018 Nov 29.

13.

MiR224-3p inhibits hypoxia-induced autophagy by targeting autophagy-related genes in human glioblastoma cells.

Guo X, Xue H, Guo X, Gao X, Xu S, Yan S, Han X, Li T, Shen J, Li G.

Oncotarget. 2015 Dec 8;6(39):41620-37. doi: 10.18632/oncotarget.5871.

14.

Intronic miRNA-641 controls its host Gene's pathway PI3K/AKT and this relationship is dysfunctional in glioblastoma multiforme.

Hinske LC, Heyn J, Hübner M, Rink J, Hirschberger S, Kreth S.

Biochem Biophys Res Commun. 2017 Aug 5;489(4):477-483. doi: 10.1016/j.bbrc.2017.05.175. Epub 2017 May 30.

PMID:
28576488
15.

miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway.

Li H, Chen L, Li JJ, Zhou Q, Huang A, Liu WW, Wang K, Gao L, Qi ST, Lu YT.

J Hematol Oncol. 2018 May 29;11(1):70. doi: 10.1186/s13045-018-0618-0.

16.

The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.

Wu W, Yu T, Wu Y, Tian W, Zhang J, Wang Y.

J Exp Clin Cancer Res. 2019 Mar 21;38(1):133. doi: 10.1186/s13046-019-1132-0.

17.

TDP-43/HDAC6 axis promoted tumor progression and regulated nutrient deprivation-induced autophagy in glioblastoma.

Lin TW, Chen MT, Lin LT, Huang PI, Lo WL, Yang YP, Lu KH, Chen YW, Chiou SH, Wu CW.

Oncotarget. 2017 May 18;8(34):56612-56625. doi: 10.18632/oncotarget.17979. eCollection 2017 Aug 22.

18.

Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review.

Fabian D, Guillermo Prieto Eibl MDP, Alnahhas I, Sebastian N, Giglio P, Puduvalli V, Gonzalez J, Palmer JD.

Cancers (Basel). 2019 Feb 2;11(2). pii: E174. doi: 10.3390/cancers11020174. Review.

19.

Ibrutinib, a Bruton's tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma.

Wang J, Liu X, Hong Y, Wang S, Chen P, Gu A, Guo X, Zhao P.

J Exp Clin Cancer Res. 2017 Jul 17;36(1):96. doi: 10.1186/s13046-017-0549-6.

20.

Curcumin and Solid Lipid Curcumin Particles Induce Autophagy, but Inhibit Mitophagy and the PI3K-Akt/mTOR Pathway in Cultured Glioblastoma Cells.

Maiti P, Scott J, Sengupta D, Al-Gharaibeh A, Dunbar GL.

Int J Mol Sci. 2019 Jan 18;20(2). pii: E399. doi: 10.3390/ijms20020399.

Supplemental Content

Support Center